Novo Nordisk is facing difficulties to replace the existing drug Saxenda (liraglutide) with a new drug Wegovy (semaglutide) in the obesity treatment market due to manufacturing issues.On Thursday, the Danish multinational drugmaker said in an IR meeting for second-quarter earnings that it would be d
Macrogen, a company specializing in precision medicine biotechnology, said on Monday that it is expanding its multiomics business by providing domestic and foreign protein analysis services.Multiomics is a high-level analytical technique that integrates genomic, transcriptome, and proteome data, and
Bukwang Pharmaceutical its subsidiary Dyna Therapeutics obtained a composition patent for SOL-804, a prostate cancer drug candidate, in Korea and Japan.With the additional two patent registrations, Dyna has completed the patent registration in 32 countries including the U.S., Australia, Mexico, and
HLB Life Science, which owns rights to market Jiangsu Hengrui Medicine’s anticancer drug pyrotinib in Korea, said it would expand new pipelines on the back of the recent success of a phase 3 pyrotinib trial.Jiangsu Hengrui announced that the phase 3 clinical trial of pyrotinib met the primary endpoi
SillaJen announced Thursday that it tapped Kim Jae-kyung, a former head of LabGenomics, as the new CEO.With Kim taking the helm, SillaJen said it would be able to normalize stock trading and strengthen corporate transparency.Kim was a founding member and CEO of LabGenomics. He also served as an adju
ATGC said Thursday that it signed a strategic partnership license and supply agreement with RELIFE, an Italian biopharma firm, for its botulinum toxin type A (ATGC-100) as part of its strategic entry into Europe.Under the agreement, ATGC will grant RELIFE exclusive rights to develop, register, promo
Bridge Biotherapeutics announced that it would release non-clinical data of idiopathic pulmonary fibrosis (IPF) treatment candidates BBT-301 and BBT-209 at the IPF summit 2022 to be held at Boston from Aug. 29 to Sept. 1.According to the company, BBT-301 is a novel drug candidate which fights the di
Medytox’s plan to enter the Chinese botulinum toxin (BTX) market is suffering a setback as Bloomage Biotechnology, its Chinese partner, announced that it would terminate its deal with Medytox.According to Chinese media outlets, Bloomage has hired a lawyer to issue an official notice to exercise its
Biogen’s Alzheimer’s disease treatment Aduhelm (ingredient: aducanumab) may not be able to obtain marketing approval in Korea due to “insufficient data.”According to the minutes of the Central Pharmaceutical Advisory Committee’s meeting disclosed by the Ministry of Food and Drug Safety, the committe
Reyon Pharmaceutical said it would expand business partnerships at the Bioplus-Interphex Korea 2022, Korea’s largest biotech convention held at COEX, Seoul.At the BIX 2022, Reyon Pharmaceutical will seek partners for co-development and CDMO/CMO business by promoting its cGMP biologic drug factory lo
The government approved Takeda’s human protein C to treat severe congenital protein C deficiency, an extremely rare disease with only 13 Korean cases reported so far.On Tuesday, the Ministry of Food and Drug Safety authorized the use of Ceprotin (ingredient: human protein C) to prevent and treat ven
GC Biopharma announced on Monday that operating profit for the second quarter of 2022 jumped by 18 percent on year recording 13.1 billion won ($10 million).Sales stood at 423.2 billion won in the second quarter, up 9.2 percent year-on-year. Net profit jumped 45.3 percent to 10.9 billion won in the s
Samjin Pharmaceutical signed an agreement with Cyclica, a Canadian AI-based novel drug development platform company, for a joint research on AI novel drug development.Under the agreement, Samjin Pharmaceutical will propose several potential drug candidates to Cyclica, and Cyclica will apply its AI-b
Helixmith is facing additional delays in receiving a recommendation from the Independent Data Monitoring Committee (IDMC) for its U.S. phase 3 clinical trial of Engensis (VM202), its diabetic peripheral neuropathy (DPN) treatment.Industry sources said the IDMC interim results could predict whether t
Samsung Biologics said on Tuesday it completed the first engineering run of its one-stop production system for large-scale commercial production of mRNA Covid-19 vaccine raw materials, following the contract manufacturing organization (CMO) for Moderna's mRNA vaccine.Greenlight Bioscience and Samsun
ST Pharm announced on Monday it won the U.S. FDA’s current Good Manufacturing Practice (cGMP) certification for its oligonucleotide (oligo) plant in Korea, for the first time in Asia.An FDA inspection team visited ST Pharm’s oligo factory in Banwol in Ansan in May and conducted a pre-approval inspec
A research team at St. Mary's Hospital has discovered that T cell, which causes autoimmune liver disease, appears after a liver biopsy on patients who received the Covid-19 vaccine.The research, conducted by Professors Sung Pil-soo at Seoul St. Mary's Hospital and Lee Sun-kyu at Incheon St. Mary's H
Novartis Korea said Monday that it released Zolgensma, the nation's first gene replacement treatment for spinal muscular atrophy (SMA), on Monday with the registration of health insurance benefits.SMA is a fatal rare genetic disease and one of the main causes of infant death, in which muscles gradua
Celltrion began the domestic sale of its Alzheimer's dementia treatment, Donerion Patch (ingredient name: donepezil), on Monday.Donerion, the first patch-type donepezil-based dementia treatment worldwide, received approval from the Ministry of Food and Drug Safety (MFDS) in November and began to get
Eli Lilly Korea said Monday that it has appointed Christopher J. Stokes, general manager at Eli Lilly South Africa and Sub Saharan Africa, as its new general manager.The current general manager, Alberto Riva, has been appointed as the head of Eli Lilly Brazil.Stokes, who first joined Eli Lilly's U.S